<DOC>
	<DOCNO>NCT00290550</DOCNO>
	<brief_summary>This study evaluate effectiveness investigational drug patient cancer lung .</brief_summary>
	<brief_title>A Phase IIA Study MK0457 Patients With Cancer Lung ( 0457-006 )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patients least 18 year age cancer lung either previous treatment 1 previous treatment advance cancer lung . Certain treatment may also allow ( prior cytotoxic chemotherapy adjuvant setting ) Patients treatment investigational therapy within past 30 day eligible . Patients disease medical condition control eligible . Patients pregnant breastfeed eligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Advanced Non-Small Cell Lung Cancer</keyword>
	<keyword>NSCLC</keyword>
</DOC>